Inovio Tech: How good?

Here is a list of studies and their status:

Here is a partial list of further viruses:

from Inovio: "We have developed SynCon® vaccines against Clostridium difficile, tuberculosis, foot-and-mouth disease (for animals), malaria, dengue fever, Chikungunya virus, and other tropical infectious diseases, some which pose potential risk for bioterrorism use."

It appears that any virus that has a protein coat with a known sequence can be used in making a DNA vaccine.

How safe? So far no side effects at all have been reported except a small reddening at the site where the DNA was introduced.

Recognitions:
1. Inovio's SynCon vaccine was named Best Therapeutic Vaccine in 2014 and 2015 by the World Vaccine Congress/

2. CEO named "Entrepreneur of the year" by Ernst and Young on June 12, 2015.

Biggest obstacle? The FDA's rule of having to perform a P1, P2 and P3 study for every indication.